Clinical Trial Update: Imaging of Traumatic Brain Injury Metabolism Using Hyperpolarized Carbon-13 Pyruvate [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial at UT Southwestern is investigating metabolic imaging of traumatic brain injury using hyperpolarized carbon-13 pyruvate. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Hyperpolarized Carbon-13 Pyruvate (Hyperpolarized carbon-13 pyruvate)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Traumatic Brain Injury | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION